On October 23, the "Forum on Promoting the High-quality Development of Ganoderma Industry" was held in Hangzhou with the theme of "Good Ganoderma in China, a New Benchmark in Immunity".
More than 300 people from all over the country engaged in the research and industrial development of Ganoderma lucidum participated in this forum.
"2021 is a critical period to welcome the dawn of the post-epidemic era. The people's demand for traditional Chinese medicine services is increasingly urgent, and the high-quality development of traditional Chinese medicine has become a major national strategy." Academician of the Chinese Academy of Engineering, winner of the national honorary title of "People's Hero", National Traditional Chinese Medicine Zhang Boli, chairman of the Innovation Alliance for Material Standardization and Quality Evaluation, said in his speech that it is necessary to continuously improve the quality of Chinese medicinal materials, strengthen basic subject research, promote standardized planting, achieve "three nos and one perfect", and ensure the healthy development of Chinese medicine with pollution-free medicinal materials. .
Ganoderma lucidum, known as the "fairy grass", is a traditional and precious Chinese medicinal material that has been passed down for thousands of years.
In 2020, Ganoderma lucidum has officially become an important pilot species included in the "Food and Drug Quality" list of the National Health Commission.
As one of the key production areas of authentic medicinal materials in China, Zhejiang, the new and old "Eight of Zhejiang" authentic medicinal materials represented by Ganoderma lucidum and Dendrobium officinale have an important position in the development of Chinese medicine in the country.
"For the Ganoderma industry, extending the industrial chain, enhancing the added value of products, and enhancing market competitiveness are the development directions of the industry." Li Yu, academician of the Chinese Academy of Engineering and chairman of the International Society of Medicinal Fungi, pointed out that the seed and seedling project is the development of Chinese medicine. Basic engineering.
He mentioned that Shouxiangu has successfully bred 8 rare Chinese medicinal materials and rare edible and medicinal fungi such as Ganoderma lucidum and Dendrobium officinale with independent intellectual property rights. Among them, "Xianzhi No. 1" and "Xianzhi No. 2" have not only changed China's long-term dependence on foreign varieties of Ganoderma lucidum has also promoted the healthy development of the entire industry.
"The quality of medicinal materials is related to the health of millions of people. As an enterprise, it is not only necessary to have the spirit of self-discipline, but more importantly, to avoid problems through reasonable industrial planning and a complete industrial chain." Chairman Shou Xiangu Li Mingyan believes that for many years, Shouxiangu has focused on ensuring the safety, effectiveness, stability, and control of Chinese medicinal materials through "independent breeding-establishment of large-scale and standardized wild-like organic cultivation-intensive processing research and development-clinical application and pharmacology. Research" a complete TCM industry chain system and a complete quality traceability system to ensure the quality and safety of medicinal materials and their products.
Shouxiangu also undertook to formulate as many as 85 industry standards including the ISO International Standard for Chinese Medicine-Ganoderma lucidum.
"Standardization is the right to speak, it is the crystallization of technological integration and cohesion."
Professor Zhuang Hong, the executive deputy secretary-general of the International Exchange and Cooperation Committee of China Association of Chinese Materia Medica and Secretary-General of the Lingzhi Special Committee, who participated in the dialogue of this forum, said that the international standards of Lingzhi were formulated under the leadership of Shouxiangu, which marked China's transformation from a big country of Lingzhi to a powerful country of Lingzhi. A solid step has been taken.
During this event, the preparation of the "Blue Book of Ganoderma and Spore Powder Regulating Immunity Research" was officially launched.
The Blue Book was jointly compiled by the Zhejiang Provincial Traditional Chinese Medicine Health Consortium, the National Traditional Chinese Medicine Standardization and Quality Assessment Innovation Alliance Zhejiang Liaison Station, and Zhejiang Shouxiangu Institute of Botanical Medicine.
(Wang Limei)